Embecta Corp. (FRA:JX7)

Market Cap	528.79M -51.7%
Revenue (ttm)	920.82M -3.8%
Net Income	81.31M +21.8%
EPS	1.38 +20.9%
Shares Out	n/a
PE Ratio	6.50
Forward PE	3.64
Dividend	0.53 (6.35%)
Ex-Dividend Date	Dec 5, 2025

Volume	n/a
Average Volume	30
Open	8.40
Previous Close	8.45
Day's Range	8.40 - 8.40
52-Week Range	7.80 - 18.30
Beta	n/a
RSI	28.43
Earnings Date	Feb 5, 2026

About Embecta

Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company’s products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient’s diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1924
• Employees: 1,850
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: JX7

Financial Performance

In fiscal year 2025, Embecta's revenue was $1.08 billion, a decrease of -3.80% compared to the previous year's $1.12 billion. Earnings were $95.40 million, an increase of 21.84%.

Financial numbers in USD